Homeopathic medications that are useful to public health and available to everyone
Boiron came into being in 1932, when Jean and Henri Boiron, the company’s founders, who were scientists and entrepreneurs at heart, set up the company. In 2016, Boiron remains an independent, family-run laboratory — something of an exception in the international pharmaceutical field. Christian Boiron, son of Jean Boiron, is the company’s Director-General.
The company’s independence means that Boiron remains the master of its strategic choices. Boiron makes medications that are useful to public health and available to everyone — be they health professionals or the general public. Today, the group is present in more than 50 countries and continues the work of its founders, who were pioneers in the development of homeopathic medications worldwide. Boiron manufactures Camilia® teething medicine for use in the relief of teething pain and other associated minor symptoms in babies and infants.
In 2013, Boiron had a turnover of £500 million and employed 3,800 staff. The company is headquartered in Lyon (south-eastern France) and has a representative in the UK. For further information about the company, please visit http://www.boiron.com